RecruitingNCT05153694

Infectious Complications After Cystectomy: A Prospective Observational Study


Sponsor

Ludwig-Maximilians - University of Munich

Enrollment

200 participants

Start Date

Dec 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.


Eligibility

Inclusion Criteria1

  • Disease which requires removal of the urinary bladder

Exclusion Criteria1

  • Patient does not want to participate

Interventions

PROCEDURECystectomy

Removal of the urinary bladder


Locations(1)

Urology Department - LMU Klinikum

Munich, Outside U.S./Canada, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05153694


Related Trials